Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz
Szekesfehervar, Hungary
Hospital in Székesfehérvár
Székesfehérvár, Seregélyesi út 3, 8000
About Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
11
Celgene
6
Janssen Research & Development, LLC
6
Shire
5
Takeda
4
Amgen
3
Bayer
3
Kowa Research Institute, Inc.
3
Pfizer
3
Daiichi Sankyo, Inc.
2
Eli Lilly and Company
2
Clinical Trials at Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz
During the past decade, Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz conducted 52 clinical trials. In the 10-year time frame, 52 clinical trials started and 35 clinical trials were completed, i.e. on
average, 67.3% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 19 clinical trials were completed. i.e. 105.6%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis
2006-03-01
2008-04-01
Completed
796
A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors
2006-09-01
2014-06-01
Completed
1,252
Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer
2005-12-01
2010-03-01
Completed
148
Analgesic Efficacy, Safety and Tolerability of Two Paracetamol-Containing Solutions in Post-Surgical Hip Replacement Pain
2007-08-01
2008-03-01
Completed
148
Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study
2007-03-01
2008-07-01
Completed
735
A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.
2008-02-04
2017-05-02
Completed
228
Phase III Lucanix™ Vaccine Therapy in Advanced Non-small Cell Lung Cancer (NSCLC) Following Front-line Chemotherapy
2008-07-01
2013-01-01
Completed
532
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz" #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "Celgene" with 6 trials
sponsored, "Janssen Research & Development, LLC" with 6 trials sponsored, "Shire" with 5 trials sponsored and "Takeda"
with 5 trials sponsored. Other sponsors include 45 different institutions and
companies that sponsored additional 42 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz"
#1 collaborator was "Department of Health and Human Services" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Akcea Therapeutics" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were
collaborators in the rest 15 trials.
Clinical Trials Conditions at Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz
According to Clinical.Site data, the most researched conditions in "Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz" are
"Ulcerative Colitis" (8 trials), "Crohn Disease" (6 trials), "Crohn's Disease" (5 trials), "Carcinoma, Non-Small-Cell Lung" (4 trials) and "Arthritis, Psoriatic" (3 trials). Many other conditions were trialed in "Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz" in a lesser frequency.
Clinical Trials Intervention Types at Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz
Most popular intervention types in "Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz" are "Drug" (72 trials), "Other" (12 trials), "Biological" (9 trials), "Combination Product" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (36 trials), "Ontamalimab" (4 trials), "Bevacizumab" (3 trials), "Etrolizumab" (3 trials) and "K-877" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz
The vast majority of trials in "Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz" are
78 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz
Currently, there are NaN active trials in "Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz".
undefined are not yet recruiting,
12 are recruiting,
13 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 41 completed trials in Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz,
undefined suspended trials,
and 15 terminated clinical trials to date.
Out of the total trials that were conducted in Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz, 1 "Phase 1"
clinical trials were conducted, 14 "Phase 2" clinical
trials and 59 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 1 trials that are defined as “Not Applicable".
Departments of Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz
Fejer Megyei Szent Gyorgy Egyetemi Oktato Korhaz has several departments that took part in Clinical trials: "Fejér Megyei Szent György Kórház; Onkológiai Osztály" - 2 trials
Departments List
Name
City
Trials